UnitedHealth Group Incorporated $UNH Shares Sold by Corundum Group Inc.

Corundum Group Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 70.2% during the second quarter, HoldingsChannel reports. The firm owned 729 shares of the healthcare conglomerate’s stock after selling 1,718 shares during the quarter. Corundum Group Inc.’s holdings in UnitedHealth Group were worth $227,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Retirement Planning Group LLC increased its stake in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after purchasing an additional 21 shares during the last quarter. Net Worth Advisory Group increased its stake in UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares during the last quarter. Bensler LLC increased its stake in UnitedHealth Group by 0.3% during the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after purchasing an additional 22 shares during the last quarter. Lakeridge Wealth Management LLC grew its position in shares of UnitedHealth Group by 5.8% during the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock worth $220,000 after acquiring an additional 23 shares during the last quarter. Finally, Broadway Wealth Solutions Inc. lifted its holdings in UnitedHealth Group by 2.1% in the 1st quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate’s stock valued at $603,000 after acquiring an additional 24 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.8%

Shares of NYSE:UNH opened at $360.17 on Friday. The firm has a fifty day moving average of $307.84 and a two-hundred day moving average of $355.58. The firm has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

Several analysts recently commented on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Finally, Robert W. Baird reiterated an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.